错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Management of an older Marshall-Smith syndrome patient: a review of literature of MSS and craniosynostosis

  • Eeshan Khurana,
  • Jennifer Orth,
  • Beth Pletcher,
  • Roger E. Turbin,
  • Catherine A. Mazzola

摘要

Marshall-Smith Syndrome (MSS) is a rare progressive developmental disorder that severely impairs a patient’s intellectual development and physical health. The only known cause for MSS is a mutation in the nuclear factor 1 X (NFIX) gene. This mutation affects neuronal development and protein transcription. Historically, most patients with MSS do not survive beyond 3 years of age. Reports of ocular findings are limited. We report a case of a 9-year-old MSS patient with progressive craniosynostosis, elevated intracranial pressure, and catastrophic ocular complications. A comprehensive PubMed literature search from 2018 to August 2022 updating a previous review of older literature produced 72 articles relating to MSS, which are reviewed.